INSULIN SENSITIVITY IS DECREASED IN NORMAL WOMEN BY DOSES OF ETHINYL ESTRADIOL USED IN ORAL-CONTRACEPTIVES

被引:36
作者
KOJIMA, T [1 ]
LINDHEIM, SR [1 ]
DUFFY, DM [1 ]
VIJOD, MA [1 ]
STANCZYK, FZ [1 ]
LOBO, RA [1 ]
机构
[1] UNIV SO CALIF,SCH MED,DEPT OBSTET & GYNECOL,DIV REPROD ENDOCRINOL & INFERTIL,LOS ANGELES,CA 90033
关键词
INSULIN SENSITIVITY; INSULIN CLEARANCE; INSULIN; GLUCOSE; ETHINYL ESTRADIOL; NORETHINDRONE ACETATE;
D O I
10.1016/0002-9378(93)90432-I
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: We determined the independent effects of various doses of ethinyl estradiol used in oral contraceptives or norethindrone acetate, as well as their combination, on insulin sensitivity in normal women. STUDY DESIGN: Thirty-three normal ovulatory female volunteers were recruited for this study. Insulin tolerance tests were performed after carbohydrate loading to determine the kinetic disappearance of glucose and insulin. After initial testing the women were randomized into four groups: ethinyl estradiol 20 mug, 35 mug, and 50 mug and norethindrone 1 mg. Insulin tolerance tests were repeated after 1 month of treatment and again after a second month, when all ethinyl estradiol groups received the addition of norethindrone 1 mg to their doses of ethinyl estradiol. Plasma glucose and insulin were measured, and insulin sensitivity (K(itt) glucose) and the disappearance of insulin (K(itt) insulin) were calculated. RESULTS: All groups were comparable at baseline, and no significant changes in fasting glucose and insulin were evident with treatment. After ingestion of 50 mug ethinyl estradiol the K(itt) glucose value decreased significantly (p < 0.03) and ingestion of 20 mug and 35 mug showed individual changes, but as groups the changes were not statistically significant. All ethinyl estradiol groups combined had a significant decrease in K(itt) glucose (p < 0.01). Norethindrone 1 mg alone did not change K(itt) glucose values, and after the addition of norethindrone to ethinyl estradiol, K(itt) glucose values normalized. K(itt) insulin values were also lower with treatment but were lower with ethinyl estradiol plus norethindrone compared with ethinyl estradiol alone (p < 0.04), suggesting an attenuation of insulin clearance with the progestin. CONCLUSION: Ethinyl estradiol alone decreases insulin sensitivity, and this may occur at lower doses, but norethindrone 1 mg does not appear to do so. However, progestins may alter insulin clearance.
引用
收藏
页码:1540 / 1544
页数:5
相关论文
共 22 条
[1]   ASSESSMENT OF INSULIN SENSITIVITY INVIVO [J].
BERGMAN, RN ;
FINEGOOD, DT ;
ADER, M .
ENDOCRINE REVIEWS, 1985, 6 (01) :45-86
[2]   ESTIMATES OF INVIVO INSULIN ACTION IN MAN - COMPARISON OF INSULIN TOLERANCE-TESTS WITH EUGLYCEMIC AND HYPERGLYCEMIC GLUCOSE CLAMP STUDIES [J].
BONORA, E ;
MOGHETTI, P ;
ZANCANARO, C ;
CIGOLINI, M ;
QUERENA, M ;
CACCIATORI, V ;
CORGNATI, A ;
MUGGEO, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (02) :374-378
[3]   TRIPHASIC RANDOMIZED CLINICAL-TRIAL - COMPARISON OF EFFECTS ON CARBOHYDRATE-METABOLISM [J].
BOWES, WA ;
KATTA, LR ;
DROEGEMUELLER, W ;
BRIGHT, TG .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 161 (05) :1402-1407
[4]   THE EFFECTS OF DIFFERENT FORMULATIONS OF ORAL-CONTRACEPTIVE AGENTS ON LIPID AND CARBOHYDRATE-METABOLISM [J].
GODSLAND, IF ;
CROOK, D ;
SIMPSON, R ;
PROUDLER, T ;
FELTON, C ;
LEES, B ;
ANYAOKU, V ;
DEVENPORT, M ;
WYNN, V .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (20) :1375-1381
[5]   CLINICAL AND METABOLIC CONSIDERATIONS OF LONG-TERM ORAL-CONTRACEPTIVE USE [J].
GODSLAND, IF ;
CROOK, D ;
WYNN, V .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 166 (06) :1955-1963
[6]  
GODSLAND IF, 1991, J CLIN ENDOCR METAB, V74, P64
[7]   COATED CHARCOAL IMMUNOASSAY OF INSULIN [J].
HERBERT, V ;
LAU, KS ;
GOTTLIEB, CW ;
BLEICHER, SJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1965, 25 (10) :1375-+
[8]   EFFECTS OF ETHINYL ESTRADIOL COMBINED WITH DESOGESTREL AND CYPROTERONE-ACETATE ON GLUCOSE-TOLERANCE AND INSULIN-RESPONSE TO AN ORAL GLUCOSE-LOAD - A ONE-YEAR RANDOMIZED, PROSPECTIVE, COMPARATIVE TRIAL [J].
JANDRAIN, BJ ;
HUMBLET, DMP ;
JAMINET, CB ;
SCHEEN, AJ ;
GASPARD, UJ ;
LEFEBVRE, PJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (01) :378-381
[9]   PROSPECTIVE STUDIES OF INSULIN SENSITIVITY IN NORMAL WOMEN RECEIVING ORAL-CONTRACEPTIVE AGENTS [J].
KASDORF, G ;
KALKHOFF, RK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (04) :846-852
[10]   THE METABOLIC IMPACT OF ORAL-CONTRACEPTIVES [J].
KRAUSS, RM ;
BURKMAN, RT .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 167 (04) :1177-1184